PMID- 31415780 OWN - NLM STAT- MEDLINE DCOM- 20200115 LR - 20200115 IS - 1527-9995 (Electronic) IS - 0090-4295 (Linking) VI - 133 DP - 2019 Nov TI - The Minimum Clinically Important Difference of the International Consultation on Incontinence Questionnaires (ICIQ-UI SF and ICIQ-LUTSqol). PG - 91-95 LID - S0090-4295(19)30712-5 [pii] LID - 10.1016/j.urology.2019.08.004 [doi] AB - OBJECTIVE: To estimate the minimum clinically important difference (MCID) of the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) and the International Consultation on Incontinence Questionnaire-Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol) using both anchor-based and distribution-based methods for women with stress urinary incontinence undergoing nonsurgical treatment. MATERIALS AND METHODS: Data from a randomized clinical trial evaluating efficacy of a nonsurgical intervention in women with stress urinary incontinence were used for analyses. The overall score of ICIQ-UI SF ranges from 0 to 21, with greater values indicating increased severity. The ICIQ-LUTSqol ranges from 19 to 76, with greater values indicating increased impact on quality of life. Instruments used in the anchor-based method were the Patient Global Impression of Improvement, patient satisfaction, 1-hour pad test and the incontinence episode frequency. The distribution-based method used an effect size of 0.5 standard deviation. Triangulation of findings was used to converge on a single value of MCID. RESULTS: At 12-month post-treatment, 106 (88.3%) participants completed the follow-up and were included in the analysis. Anchor-based MCIDs of the ICIQ-UI SF were between 3.4 and 4.4, while the distribution-based MCID was 1.7. Anchor-based MCIDs of the ICIQ-LUTSqol were between 4.8 and 6.9, while the distribution-based MCID was 5.2. Triangulation of findings showed that MCIDs of 4 for ICIQ-UI SF and 6 for ICIQ-LUTSqol were the most appropriate. CONCLUSION: For women undergoing nonsurgical treatments for incontinence, reductions of 4 and 6 points in ICIQ-UI SF and ICIQ-LUTSqol, respectively are perceived as clinically meaningful. CI - Copyright (c) 2019 Elsevier Inc. All rights reserved. FAU - Lim, Renly AU - Lim R AD - School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia; Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia. Electronic address: renly_lim@hotmail.com. FAU - Liong, Men Long AU - Liong ML AD - Department of Urology, Island Hospital, Penang, Malaysia. FAU - Lim, Ka Keat AU - Lim KK AD - Programme in Health Services and Systems Research, Duke University-National University of Singapore (Duke-NUS) Medical School, Singapore. FAU - Leong, Wing Seng AU - Leong WS AD - Department of Urology, Lam Wah Ee Hospital, Penang, Malaysia. FAU - Yuen, Kah Hay AU - Yuen KH AD - School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia. LA - eng PT - Comparative Study PT - Journal Article PT - Randomized Controlled Trial DEP - 20190812 PL - United States TA - Urology JT - Urology JID - 0366151 SB - IM MH - *Diagnostic Self Evaluation MH - Female MH - Humans MH - Lower Urinary Tract Symptoms/diagnosis MH - Middle Aged MH - *Quality of Life MH - *Self Report MH - Severity of Illness Index MH - Urinary Incontinence, Stress/*diagnosis/*therapy EDAT- 2019/08/16 06:00 MHDA- 2020/01/16 06:00 CRDT- 2019/08/16 06:00 PHST- 2019/05/09 00:00 [received] PHST- 2019/07/31 00:00 [revised] PHST- 2019/08/05 00:00 [accepted] PHST- 2019/08/16 06:00 [pubmed] PHST- 2020/01/16 06:00 [medline] PHST- 2019/08/16 06:00 [entrez] AID - S0090-4295(19)30712-5 [pii] AID - 10.1016/j.urology.2019.08.004 [doi] PST - ppublish SO - Urology. 2019 Nov;133:91-95. doi: 10.1016/j.urology.2019.08.004. Epub 2019 Aug 12.